PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,485 | +17.3% | 1,410 | 0.0% | 0.00% | – |
| Q1 2023 | $15,764 | -94.3% | 1,410 | -95.7% | 0.00% | -100.0% |
| Q4 2022 | $275,349 | -48.6% | 32,663 | +1.4% | 0.00% | -33.3% |
| Q3 2022 | $536,000 | -71.4% | 32,201 | -74.7% | 0.00% | -72.7% |
| Q2 2022 | $1,874,000 | +924.0% | 127,331 | +1630.5% | 0.01% | +450.0% |
| Q1 2022 | $183,000 | -82.1% | 7,358 | -77.0% | 0.00% | -80.0% |
| Q4 2021 | $1,025,000 | +16.9% | 31,955 | +31.0% | 0.01% | -9.1% |
| Q3 2021 | $877,000 | +81.2% | 24,384 | +122.1% | 0.01% | +120.0% |
| Q2 2021 | $484,000 | +796.3% | 10,980 | +1313.1% | 0.01% | +400.0% |
| Q4 2020 | $54,000 | – | 777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |